<DOC>
	<DOC>NCT01426568</DOC>
	<brief_summary>The purpose of this study is to determine whether multi-convergent therapy is helpful to patients with inflammatory bowel disease who have functional abdominal symptoms or high perceived levels of psychological stress.</brief_summary>
	<brief_title>A Trial of Multi-convergent Therapy for Functional Symptoms and Stress in Patients With Inflammatory Bowel Disease</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Diagnosis of Inflammatory Bowel Disease Clinical Remission of inflammatory bowel disease as defined by an adapted disease activity index and a CRP &lt;10 Age 18 to 65 years Evidence of irritable bowel syndrome (Rome III criteria) or high perceived stress level (Levenstein perceived stress score &gt; 0.44) Use of steroids within 1 month of entry to study Initiation or change in dose of medication within 1 month of entry to the study Presence of ileostomy or colostomy Diagnosis of dementia or cognitive impairment Current psychosis or substance misuse Change in psychotropic medication in 3 months prior to entry to study Previous psychological interventions Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Multi-Convergent Therapy</keyword>
	<keyword>Mindfulness Meditation</keyword>
	<keyword>Functional Abdominal Symptoms</keyword>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>Psychological Stress</keyword>
</DOC>